期刊文献+

表皮生长因子受体及HER-2/neu蛋白在胃癌中的表达和意义 被引量:12

Signification and Expression of EGFR and HER-2/neu Proteins in Gastric Cancer
下载PDF
导出
摘要 目的探讨表皮生长因子受体(EGFR)、HER-2/neu蛋白在胃癌中的表达及其与预后的关系。方法回顾性分析2006年11月至2013年11月我院收治的90例胃癌患者(观察组)的临床资料,另选取正常胃组织50例作为对照组。观察2组EGFR、HER-2/neu蛋白的表达情况,分析胃癌组织中EGFR、HER-2/neu蛋白表达和临床病理特征的关系。结果观察组EGFR、HER-2/neu蛋白表达阳性率高于对照组,差异均有统计学意义(P<0.05)。EGFR、HER-2/neu蛋白表达和胃癌患者的性别、年龄、肿瘤部位、肿瘤直径无相关性(P>0.05),而与胃癌分化程度、临床分期、浸润深度、淋巴结转移、远处转移密切相关,差异均有统计学意义(P<0.05)。EGFR与HER-2/neu表达呈正相关。结论 EGFR、HER-2/neu蛋白的表达与胃癌的发生发展密切相关。EGFR与HER-2/neu的表达呈正相关。 Objective To study the expressions of EGFR and HER-2/neu proteins in gastric carcinoma and the conditions of prognosis. Methods The clinical data of 90 gastric cancer patients during November 2006 to November 2013 were chosen as the observation group,and 50 cases of normal gastric tissues were chosen as the control group. The expressions of EGFR and HER-2/neu proteins in the two groups were measured by immunohistochemical staining to analyze the relationship of their expression with clinical features. Results The positive rate of EGFR and HER-2/neu expressions in the observation group was higher than the control group,with statistical significance(P〈0.05). The expressions of EGFR and HER-2/neu proteins were closely related with differentiation,clinical stages,mucosa invasion depth,lymphatic metastasis,distant metastasis of gastric cancer,with statistical significance(P〈0.05),however,no relations were detected with gender,age,tumor size and tumor site(P〉0.05). The expression of EGFR showed a positive correlation with HER-2/neu. Conclusion There was a close relationship of EGFR and HER-2/neu expressions with the onset and progression of gastric cancer. The expression of EGFR showed a positive correlation with HER-2/neu.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2015年第9期829-832,共4页 Journal of China Medical University
关键词 表皮生长因子受体 HER-2/NEU 蛋白 胃癌 表达 预后 epidermal growth factor receptor HER-2/neu protein gastric cancer expression prognosis
  • 相关文献

参考文献6

二级参考文献41

共引文献146

同被引文献90

  • 1李景武,梁寒,王晓娜.814例胃癌患者的预后因素分析[J].中国肿瘤临床,2006,33(7):399-402. 被引量:37
  • 2陈斌,罗荣城,黄宇贤,丁彦青.EGFR、HER-2/neu蛋白在胃癌中的表达及其预后价值研究[J].解放军医学杂志,2007,32(8):856-859. 被引量:11
  • 3何松,邵伟伟,王东林,陈莉,张建兵,王建红,周建云,郭燕.影响胃癌预后因素的Cox回归分析[J].郑州大学学报(医学版),2008,43(1):112-115. 被引量:4
  • 4Chabner B A,Roberts T G Jr.Timeline:chemotherapy and the war on cancer[J].Nat Rev Cancer,2005,5(1):65-72.
  • 5Lee C,Raffaghello L,Brandhorst S,et al.Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy[J].Sci Transl Med,2012,4(124):124-127.
  • 6Guo X L,Li D,Hu F,et al.Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells[J].Cancer Lett,2012,320(2):171-179.
  • 7Dutta P R,Maity A.Cellular responses to EGFR inhibitor and their relevance to cancer therapy[J].Cancer Lett,2007,254(2):165-177.
  • 8Yoon H,Min J K,Lee J W,et al.Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of Akt and extracellular signal-regulated kinase(ERK)1/2[J].Biochem Biophys Res Commun,2011,405(3):333-337.
  • 9Hoffmann K,Xiao Z,Franz C,et al.Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro[J].Cancer Cell Int,2011,11:40.
  • 10Chen S J,Luan J,Zhang H S,et al.EGFR-mediated G1/S transition contributes to the multidrug resistance in breast cancer cells[J].Mol Biol Rep,2012,39(5):5465-5471.

引证文献12

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部